| Short Description : | Beta crystallin S Blocking Peptide for STJ500311 is synthetically produced from the 120-178 sequence and is suitable for use in western blot applications. |
| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | Crygs |
| Gene ID: | 12970 |
| Uniprot ID: | CRYGS_MOUSE |
| Immunogen: | C-epitope Synthetic peptide taken within amino acid region 120-178 on mouse BXTIS protein. |
| Immunogen Region: | 120-178 |
| Specificity: | This blocking peptide is recommended for use in combination with Beta crystallin S antibody, STJ500311 |
| Function | Crystallins are the dominant structural components of the vertebrate eye lens. |
| Peptide Name | Gamma-Crystallin SBeta-Crystallin SGamma-S-Crystallin |
| Alternative Peptide Names | Gamma-Crystallin S proteinBeta-Crystallin S proteinGamma-S-Crystallin proteinCrygs protein |
Information sourced from Uniprot.org